RSV InfectionNCT07264478
Diagnosis and Treatment Status and Medical Burden of Respiratory Syncytial Virus Infection in Children in China
An observational study of RSV Infection and Disease Burden, run by Beijing Children's Hospital at 1 site in China.
Trial summary
To understand the diagnosis and treatment status and medical burden of respiratory syncytial virus (RSV) infection in children in China, and to provide scientific basis for formulating prevention and treatment strategies for children. Read more about this study
- Who is it for?
- Ages 0 to 18 years
- Conditions the study is for
- RSV Infection, Disease Burden
- What is being tested?
- uninvolved
- How many people
- 1,100 participants
- Where
- 1 siteChina
- Study dates
- 15 Oct 2022to 30 Dec 2025
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 0 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: According to the seven administrative regions of China, namely Northeast, North, Northwest, Southwest, Central, South and East China, 1-3 children's medical institutions were selected from each region, and the cases of bronchiolitis or pneumonia admitted to hospitals and diagnosed as RSV positive by etiology during January 1, 2017 to December 31, 2021 were selected. A total of 11 hospitals were selected, each with 100 children, a total of 1100 cases
Who may be able to join
- Hospitalized patients under 18 years of age with an etiological diagnosis of RSV-positive bronchiolitis or pneumonia
Who cannot join
- Inpatients under 18 years of age with an etiological diagnosis of RSV-positive bronchiolitis or pneumonia are excluded from any of the following criteria:
- Pneumonia occurring 48 hours after hospitalization;
- Combined with bronchial foreign body;
- Participants in clinical trials of drugs or medical devices;
- Not complete personal and family history and other relevant information.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Beijing Children's Hospital, Capital Medical University, China National Clinical Research Center of Respiratory Diseases, National Center for Children's Health, Beijing, China
To understand the diagnosis and treatment status and medical burden of respiratory syncytial virus (RSV) infection in children in China, and to provide scientific basis for formulating prevention and treatment strategies for children. According to the seven administrative regions of China, namely Northeast, North, Northwest, Southwest, Central, South and East China, 1-3 children's medical institutions were selected from each region, and the cases of bronchiolitis or pneumonia admitted to hospitals and diagnosed as RSV positive by etiology during January 1, 2017 to December 31, 2021 were selected. Demographic data and clinical information were collected, and subgroup analysis was designed to explore the relationship between them and medical expenses and clinical treatment burden.
- Conditions
- RSV Infection, Disease Burden
- Being tested
- uninvolved
- Medical subject headings
- Respiratory Syncytial Virus Infections
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
uninvolvedOther
uninvolved
What is being measured
The primary outcome is the main question the study is designed to answer.
hospitalization costs
hospitalization costs,pharmcost,testcost,testcost
Measured: duration of hospital stay
Secondary outcomes (1)
hospital day
duration of hospital stay
Measured: duration of hospital stay
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Dec 2025
- Study start15 Oct 2022
- Primary completion12 Dec 2025 (estimated)
- Study completion30 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for RSV InfectionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 1,100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Beijing Children's Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Baoping XU, Beijing Children's Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07264478
- Sponsor's protocol ID
- BCH lung 22
- Status last verified
- Dec 2025
- First submitted
- 12 Oct 2023
- Last updated
- 4 Dec 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No